Image

Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease

Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Numerous clinical studies have highlighted the role of macrophages in the destabilization of coronary lesions; however, there is limited literature on the relationship between circulating monocytes and intraplaque macrophages.

This study aims to evaluate and compare the presence of macrophages and their subsequent activation within coronary and peripheral atherosclerotic lesions, and to correlate these findings with the distribution of circulating monocyte subpopulations.

Eligibility

Inclusion Criteria:

  • Patients with chronic coronary artery disease;
  • Patients with no-ST elevation acute coronary syndrome;
  • Patients with chronic claudication (Rutherford II-III)
  • Patients with critical limb ischemia (Rutherford IV-V).

Exclusion Criteria:

  • Severe renal dysfunction
  • Severe valve disease
  • Advanced heart failure
  • Advanced liver disease
  • Chronic inflammatory or autoimmune disease
  • Use of antinflammatory drugs
  • Acute infection
  • Recent surgical procedures

Study details
    Stable Coronary Artery Disease
    Acute Coronary Syndromes
    Critical Limb Ischemia
    Intermittent Claudication

NCT07588295

Maria Cecilia Hospital

27 June 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.